Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Cellular and Molecular Medicine|July 9, 2020
Association of plasma exosomes with severity of organ failure and mortality in patients with sepsisYunjoo Im, Hongseok Yoo, Jin Young Lee, et al.
Chest|November 18, 2021
Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause MortalityYunjoo Im, Na Young Hwang, Kyunga Kim, et al.
Respiratory Medicine|February 15, 2020
Development of tuberculosis in cancer patients receiving immune checkpoint inhibitorsYunjoo Im, Jeeyun Lee, Seok Jin Kim, et al.
Scientific Reports|July 2, 2025
Increased risk of lung cancer in individuals with preserved ratio impaired spirometry: a nationwide cohort studyTaeyun Kim, Junsu Choe, Yunjoo Im, et al.
Respiratory Research|March 30, 2024
Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort studyTaeyun Kim, Sun Hye Shin, Hyunsoo Kim, et al.
Respiratory Medicine Case Reports|October 20, 2018
A rare case of numerous thoracolithiasis with chest discomfortNoeul Kang, Yeonseok Choi, Yunjoo Im, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2020
BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary DiseaseHyung-Jun Kim, Nakwon Kwak, Hyunsook Hong, et al.
European Journal of Radiology Open|December 28, 2020
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and managementHongseok Yoo, Takuya Hino, Joungho Han, et al.
European Journal of Radiology Open|January 9, 2023
Retraction notice to: "Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management" [Eur. J. Radiol. Open 8C (2021) 100311]Hongseok Yoo, Takuya Hino, Joungho Han, et al.
Translational Lung Cancer Research|May 9, 2022
The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastasesJuan Zhou, Yinfei Wu, Mengqing Xie, et al.
Pageof 5